Peru is one of the most attractive and easy-to-enter countries due to its liberal regulatory system. The introduction of universal healthcare coverage means the Peruvian pharmaceutical market is expected to grow rapidly. Peru has also signed a free trade agreement with the US, which will help enforce intellectual property laws in the country.
Despite the economic crisis, Peru’s pharmaceutical market has remained one of the most promising in Latin America, with total sales (including public and private sectors) reaching US $1.5 billion. There are plenty of opportunities for foreign manufacturers to capitalise on this fast-growing pharmaceutical market and use the increase in demand to their benefit.